US equities |
MU $1,085.08 ▲+3.78% SNDK $1,725.36 ▲+3.91% NVDA $236.88 ▼-0.99% AMD $643.09 ▼-0.98% SPCX $167.48 ▼-2.58% INTC $112.97 ▲+0.41% TSLA $376.13 ▼-1.19% AAPL $335.71 ▲+0.62%
FinancialContent

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

3.310 +0.030 (+0.91%)
Delayed Quote Updated: 1:01 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Relmada Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Relmada (RLMD) Q2 2026 Earnings Call Transcript ↗
NDV-01 Phase 2 showed 95% complete response rates, with IND filing expected by year-end. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Relmada Therapeutics Q2 Earnings Call Highlights ↗
Relmada Therapeutics (NASDAQ:RLMD) said it is prioritizing manufacturing activities for NDV-01, its sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive... 
Via MarketBeat
Topics Earnings
News headline image
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call ↗
HC Wainwright initiates Relmada Therapeutics (NASDAQ: RLMD) with a Buy rating and $12 target, highlighting its bladder cancer potential. 
Via Benzinga
News headline image
Relmada Therapeutics Q1 Earnings Call Highlights ↗
Relmada Therapeutics (NASDAQ:RLMD) said it remains on track to begin its Phase 3 RESCUE registrational program for NDV-01 in mid-2026 after reporting 12-month Phase 2 data in non-muscle invasive... 
Via MarketBeat
Topics Earnings Intellectual Property
Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Q4 2025 Earnings Miss, Stock Declines ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Relmada (RLMD) Q4 2025 Earnings Call Transcript ↗
Relmada (RLMD) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Economy
Unusual volume stocks in Tuesday's session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
Gapping stocks in Monday's session ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors ↗
Relmada stated that the therapy showed a 76% complete response rate at 12 months in high-risk non-muscle invasive bladder cancer. 
Via Stocktwits
News headline image
Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Wider-Than-Expected Q3 2025 Loss ↗
Relmada Therapeutics posts a wider-than-expected Q3 2025 loss, but reports strong 92% response rate for its bladder cancer drug NDV-01. 
Via Chartmill
News headline image
Relmada (RLMD) Q3 2025 Earnings Call Transcript ↗
Relmada (RLMD) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
A Glimpse of Relmada Therapeutics's Earnings Potential ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session. ↗
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Top movers in Friday's session ↗
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >